LUKE HOLDEN: Open Payments
NPI 1780264556 · TRAVELERS REST, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$956 in 66 payments from 14 companies in 2025. Trend: 2023 $1,104 · 2024 $1,030 · 2025 $956
Food & beverage: $956
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $181 |
| Novo Nordisk Inc | 8 | $132 |
| Lilly USA, LLC | 8 | $124 |
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| Dexcom, Inc. | 4 | $84 |
| PFIZER INC. | 5 | $81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $63 |
| Exact Sciences Corporation | 3 | $42 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
Products named: MOUNJARO, Dexcom G6 Transmitter, Ozempic, VRAYLAR, UBRELVY, XIFAXAN, FARXIGA, ELIQUIS.
Industry payments across SC — which companies pay providers there.
